These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
800 related articles for article (PubMed ID: 28235723)
21. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy. Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729 [TBL] [Abstract][Full Text] [Related]
22. Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells. Misra R; Sahoo SK Mol Pharm; 2011 Jun; 8(3):852-66. PubMed ID: 21480667 [TBL] [Abstract][Full Text] [Related]
23. Alginate Nanoparticles Containing Curcumin and Resveratrol: Preparation, Characterization, and In Vitro Evaluation Against DU145 Prostate Cancer Cell Line. Saralkar P; Dash AK AAPS PharmSciTech; 2017 Oct; 18(7):2814-2823. PubMed ID: 28397161 [TBL] [Abstract][Full Text] [Related]
24. Concurrent anti-vascular therapy and chemotherapy in solid tumors using drug-loaded acoustic nanodroplet vaporization. Ho YJ; Yeh CK Acta Biomater; 2017 Feb; 49():472-485. PubMed ID: 27836803 [TBL] [Abstract][Full Text] [Related]
25. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities. Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219 [TBL] [Abstract][Full Text] [Related]
26. Charge-conversion and ultrasound-responsive O-carboxymethyl chitosan nanodroplets for controlled drug delivery. Meng D; Guo L; Shi D; Sun X; Shang M; Zhou X; Li J Nanomedicine (Lond); 2019 Oct; 14(19):2549-2565. PubMed ID: 31271101 [No Abstract] [Full Text] [Related]
27. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors. Jiang H; Geng D; Liu H; Li Z; Cao J Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102 [TBL] [Abstract][Full Text] [Related]
28. Folate mediated self-assembled phytosterol-alginate nanoparticles for targeted intracellular anticancer drug delivery. Wang J; Wang M; Zheng M; Guo Q; Wang Y; Wang H; Xie X; Huang F; Gong R Colloids Surf B Biointerfaces; 2015 May; 129():63-70. PubMed ID: 25829128 [TBL] [Abstract][Full Text] [Related]
29. Breast cancer targeted chemotherapy based on doxorubicin-loaded bombesin peptide modified nanocarriers. Wang C; Sun X; Wang K; Wang Y; Yang F; Wang H Drug Deliv; 2016 Oct; 23(8):2697-2702. PubMed ID: 26203692 [TBL] [Abstract][Full Text] [Related]
30. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer. Wong HL; Bendayan R; Rauth AM; Wu XY J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178 [TBL] [Abstract][Full Text] [Related]
31. Carboxymethyl-hexanoyl Chitosan Nanodroplets for Ultrasonic Imaging and Drug Delivery to Tumor. Jinsui Y; Bing S; Muhua L; Yue L; Jianyi L; Meng D; Kuan C; Chaopin Y; Hui Z; Zhiyi C Curr Pharm Des; 2018; 24(15):1682-1688. PubMed ID: 29766795 [TBL] [Abstract][Full Text] [Related]
32. Ultrasound-triggered drug release and enhanced anticancer effect of doxorubicin-loaded poly(D,L-lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanodroplets. Du L; Jin Y; Zhou W; Zhao J Ultrasound Med Biol; 2011 Aug; 37(8):1252-8. PubMed ID: 21683513 [TBL] [Abstract][Full Text] [Related]
33. Chemo-photodynamic combined gene therapy and dual-modal cancer imaging achieved by pH-responsive alginate/chitosan multilayer-modified magnetic mesoporous silica nanocomposites. Yang H; Chen Y; Chen Z; Geng Y; Xie X; Shen X; Li T; Li S; Wu C; Liu Y Biomater Sci; 2017 May; 5(5):1001-1013. PubMed ID: 28327716 [TBL] [Abstract][Full Text] [Related]
34. Hybrid Mesoporous-Microporous Nanocarriers for Overcoming Multidrug Resistance by Sequential Drug Delivery. Wang L; Guan H; Wang Z; Xing Y; Zhang J; Cai K Mol Pharm; 2018 Jul; 15(7):2503-2512. PubMed ID: 29768014 [TBL] [Abstract][Full Text] [Related]
35. Nanoparticles based on oleate alginate ester as curcumin delivery system. Raja MA; Liu C; Huang Z Curr Drug Deliv; 2015; 12(5):613-27. PubMed ID: 25963307 [TBL] [Abstract][Full Text] [Related]
36. pH-sensitive Laponite(®)/doxorubicin/alginate nanohybrids with improved anticancer efficacy. Gonçalves M; Figueira P; Maciel D; Rodrigues J; Qu X; Liu C; Tomás H; Li Y Acta Biomater; 2014 Jan; 10(1):300-7. PubMed ID: 24075886 [TBL] [Abstract][Full Text] [Related]
37. Chitosan-alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer. Shen H; Li F; Wang D; Yang Z; Yao C; Ye Y; Wang X Drug Des Devel Ther; 2018; 12():921-934. PubMed ID: 29719378 [TBL] [Abstract][Full Text] [Related]
38. Doxorubicin-loaded alginate-g-poly(N-isopropylacrylamide) micelles for cancer imaging and therapy. Ahn DG; Lee J; Park SY; Kwark YJ; Lee KY ACS Appl Mater Interfaces; 2014 Dec; 6(24):22069-77. PubMed ID: 25487046 [TBL] [Abstract][Full Text] [Related]
39. Multi-drug delivery system based on alginate/calcium carbonate hybrid nanoparticles for combination chemotherapy. Wu JL; Wang CQ; Zhuo RX; Cheng SX Colloids Surf B Biointerfaces; 2014 Nov; 123():498-505. PubMed ID: 25315499 [TBL] [Abstract][Full Text] [Related]
40. pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells. Gao C; Tang F; Gong G; Zhang J; Hoi MPM; Lee SMY; Wang R Nanoscale; 2017 Aug; 9(34):12533-12542. PubMed ID: 28819666 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]